Drug intelligence / Profile preview

3-oxo-(17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-28-norolean-12(13)-ene

Development stage
Preclinical
Lead developer
Victor Babeș University of Medicine and Pharmacy Timișoara
Modality
Small Molecules
01

Overview

3-oxo-(17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-28-norolean-12(13)-ene is a semisynthetic pentacyclic triterpenoid derivative featuring a methylphosphonate moiety at the C17 position. It is derived from oleanonic acid (3-oxo-oleanolic acid), a natural phytochemical known for its anticancer potential. This specific derivative was synthesized to overcome the poor bioavailability and pharmacokinetic limitations of natural triterpenic acids. Experimental evaluations against the B164A5 murine melanoma cell line have demonstrated that the compound possesses enhanced antiproliferative and anti-migratory properties compared to its parent compound. Its mechanism of action involves the induction of apoptosis, as evidenced by nuclear condensation and dose-dependent declines in cell viability. Preliminary safety evaluations using the HET-CAM assay indicate a lack of acute vascular toxicity, suggesting its potential for further development as an antimelanoma strategy.

Other names
3-oxo-oleanolic acid dimethoxyphosphorylmethyl esteroleanonic acid dimethoxyphosphorylmethyl esterdimethoxyphosphorylmethyl 3-oxo-olean-12-en-28-oatedimethoxyphosphorylmethyl3-oxo-olean-12-en-28-oatedimethoxyphosphorylmethyl-3-oxo-olean-12-en-28-oate

Beyond the preview

Go deeper on 3-oxo-(17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-28-norolean-12(13)-ene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-oxo-(17s)-17-(((dimethoxyphosphoryl)methoxy)carbonyl)-28-norolean-12(13)-ene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call